Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes (Q61956199)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes |
clinical trial |
Statements
An Open-labelled, Randomised, Parallel Group, Multicentre, Multinational Efficacy and Safety Comparison of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30/70 as Meal Related Insulin in a Twice Daily Regimen in Type 1 and Type 2 Diabetic Subjects (English)
0 references
April 1998
0 references
September 1998
0 references
303
0 references
18 year
0 references